Phillip V. Truong, M.S. (he/him/his)

UNIVERSITY OF ROCHESTER SCHL OF MED/DENTISTRY
Rochester, New York, United States

Disclosure information not submitted.

Presentation(s):

• ORF49-07 - ETHY-001, a Half-Life Extended, TSHR Monoclonal Antibody Antagonist, Potently Inhibits TSHR Activation Induced by Patient Sera and M22-Induced Hyaluronan and IL-6 Secretion from TED Patient-Derived Orbital Fibroblasts

  Monday, June 15, 2026
  2:45 PM - 3:00 PM CT